SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000919574-05-002315
Filing Date
2005-07-19
Accepted
2005-07-19 08:19:55
Documents
1
Group Members
GEOFFREY HULMEISRAEL A. ENGLANDERJONATHAN W. FRIEDLANDMILLENCO, L.P.MILLENNIUM MANAGEMENT, L.L.C.PAUL ORLIN

Document Format Files

Seq Description Document Type Size
1 d587517_13da.txt SC 13D/A 37098
  Complete submission text file 0000919574-05-002315.txt   38984
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-47221 | Film No.: 05960499
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PORTER FELLMAN INC 100 PARK AVENUE SUITE 2120 NEW YORK NY 10017
Business Address
PORTER A ALEX (Filed by) CIK: 0001120329 (see all company filings)

Type: SC 13D/A